From Bethlehem's OraSure Technologies: Some good news on Zika
The company is hard at work on a rapid test for the virus, aided by up to $16.6 million in federal funding.
The company is hard at work on a rapid test for the virus, aided by up to $16.6 million in federal funding.
Like humans, companies start small and evolve. But instead of birth, childhood, adolescence and adulthood, they mature from intellectual capital to incubation, bootstrapping to venture capital, startup to established enterprise. We take a look at that process via four Philly companies.
Researchers at Penn State University have developed a faster and less expensive DNA sequencing method that has led to a surprising finding. The technique works for any species, so it can be used to study male infertility disorders and male-specific mutations.
Tech zillionaire and philanthropist Sean Parker has made a massive contribution to cancer research, establishing the Parker Institute for Cancer Immunotherapy at six of the nation's top medical schools and cancer centers, including the University of Pennsylvania.
This Lehigh Valley entrepreneur struck out on her own, making customized tissue culture media for labs.
This company is hard at work on a revolutionary pharmaceutical that could provide relief to those with mood disorders.
He has helped drive growth because of his diverse scientific, commercialization and entrpreneurial background, all from the comfort of Philadelphia's brainiest square mile.
The first purchase orders are coming in for his company, which is commercializing a breakthrough method to capture and hold tiny particles.
A partnership forged with a renowned sleep researcher in his backyard has led to an incredibly impactful company.
One of the city's most successful serial entrepreneurs, he co-founded wildly successful e-commerce marketing platform Monetate as well as startup accelerator DreamIt Ventures.